Black Diamond Therapeutics Inc. – Filings and Transcripts

NASDAQ: BDTX
Share price (6/11/26): $1.82
Market cap (6/11/26): $104 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

Prospectuses and Registrations Filter

Registration of securities for employees

Shelf registration

Registration of securities for employees

Registration of securities for employees

Prospectus supplement for primary offering

Ownership Filter

Vestal Point Capital, LP

News Filter

Announces Positive Phase 2 Results for Silevertinib in Frontline NSCLC Patients With EGFR Non-Classical Mutations

Reports First Quarter 2026 Financial Results and Provides Corporate Update

Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

Announces Preliminary Phase 2 Data for Silevertinib in 1L NSCLC and Plans for a Phase 2 Trial of Silevertinib in GBM

Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Other Filter

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Scanned paper annual report submission

Scanned paper annual report submission